The agreement with Pfizer-BioNTech covered 2 million doses, 200,000 of which are expected to arrive in March. The deal with Sinovac included 1,750,000 doses.
A US$120 million budget was approved for the drug purchase, which will allow the vaccination of 2,800,000 people.
Over 1,500,000 COVID-19 vaccines were also secured through the United Nations-led initiative COVAX.
Evolution of cases in Mexico, Panama, Paraguay, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Uruguay, Venezuela, since 100th confirmed case. pic.twitter.com/7ub3C12AJn
The vaccines will be first applied to health personnel, people over 75 years old, and workers of the educational system in order to resume classes with "face-to-face attendance".
Noting that there were negotiations with three other pharmaceuticals, Lacalle also informed that the vaccination would not be mandatory.
A recent report by the Honorary Scientific Advisory Group (GACH) showed that COVID-19 cases grew sharply between November and mid-December. As of Monday morning, health authorities had reported 37,633 COVID-19 cases and 376 related fatalities.